NOVEL NPR-B AGONISTS
Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HELLBERG, MARK R KNAUTE, TOBIAS HAWLISCH, HEIKO OSTERKAMP, FRANK RITCHER, UWE SIMON, BERNADETT REINEKE, ULRICH SPECKER, EDGAR REIMER, ULF WOISCHNIK, MARKUS |
| description | Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201401625B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201401625B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201401625B3</originalsourceid><addsrcrecordid>eNrjZBDx8w9z9VHwCwjSdVJwdPf38wwOCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFRjkYGhiYGhmZGpk7GxKgBAHG-HoY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL NPR-B AGONISTS</title><source>esp@cenet</source><creator>HELLBERG, MARK R ; KNAUTE, TOBIAS ; HAWLISCH, HEIKO ; OSTERKAMP, FRANK ; RITCHER, UWE ; SIMON, BERNADETT ; REINEKE, ULRICH ; SPECKER, EDGAR ; REIMER, ULF ; WOISCHNIK, MARKUS</creator><creatorcontrib>HELLBERG, MARK R ; KNAUTE, TOBIAS ; HAWLISCH, HEIKO ; OSTERKAMP, FRANK ; RITCHER, UWE ; SIMON, BERNADETT ; REINEKE, ULRICH ; SPECKER, EDGAR ; REIMER, ULF ; WOISCHNIK, MARKUS</creatorcontrib><description>Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.</description><language>eng</language><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180825&DB=EPODOC&CC=ZA&NR=201401625B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180825&DB=EPODOC&CC=ZA&NR=201401625B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HELLBERG, MARK R</creatorcontrib><creatorcontrib>KNAUTE, TOBIAS</creatorcontrib><creatorcontrib>HAWLISCH, HEIKO</creatorcontrib><creatorcontrib>OSTERKAMP, FRANK</creatorcontrib><creatorcontrib>RITCHER, UWE</creatorcontrib><creatorcontrib>SIMON, BERNADETT</creatorcontrib><creatorcontrib>REINEKE, ULRICH</creatorcontrib><creatorcontrib>SPECKER, EDGAR</creatorcontrib><creatorcontrib>REIMER, ULF</creatorcontrib><creatorcontrib>WOISCHNIK, MARKUS</creatorcontrib><title>NOVEL NPR-B AGONISTS</title><description>Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDx8w9z9VHwCwjSdVJwdPf38wwOCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFRjkYGhiYGhmZGpk7GxKgBAHG-HoY</recordid><startdate>20180825</startdate><enddate>20180825</enddate><creator>HELLBERG, MARK R</creator><creator>KNAUTE, TOBIAS</creator><creator>HAWLISCH, HEIKO</creator><creator>OSTERKAMP, FRANK</creator><creator>RITCHER, UWE</creator><creator>SIMON, BERNADETT</creator><creator>REINEKE, ULRICH</creator><creator>SPECKER, EDGAR</creator><creator>REIMER, ULF</creator><creator>WOISCHNIK, MARKUS</creator><scope>EVB</scope></search><sort><creationdate>20180825</creationdate><title>NOVEL NPR-B AGONISTS</title><author>HELLBERG, MARK R ; KNAUTE, TOBIAS ; HAWLISCH, HEIKO ; OSTERKAMP, FRANK ; RITCHER, UWE ; SIMON, BERNADETT ; REINEKE, ULRICH ; SPECKER, EDGAR ; REIMER, ULF ; WOISCHNIK, MARKUS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201401625B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>online_resources</toplevel><creatorcontrib>HELLBERG, MARK R</creatorcontrib><creatorcontrib>KNAUTE, TOBIAS</creatorcontrib><creatorcontrib>HAWLISCH, HEIKO</creatorcontrib><creatorcontrib>OSTERKAMP, FRANK</creatorcontrib><creatorcontrib>RITCHER, UWE</creatorcontrib><creatorcontrib>SIMON, BERNADETT</creatorcontrib><creatorcontrib>REINEKE, ULRICH</creatorcontrib><creatorcontrib>SPECKER, EDGAR</creatorcontrib><creatorcontrib>REIMER, ULF</creatorcontrib><creatorcontrib>WOISCHNIK, MARKUS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HELLBERG, MARK R</au><au>KNAUTE, TOBIAS</au><au>HAWLISCH, HEIKO</au><au>OSTERKAMP, FRANK</au><au>RITCHER, UWE</au><au>SIMON, BERNADETT</au><au>REINEKE, ULRICH</au><au>SPECKER, EDGAR</au><au>REIMER, ULF</au><au>WOISCHNIK, MARKUS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL NPR-B AGONISTS</title><date>2018-08-25</date><risdate>2018</risdate><abstract>Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_ZA201401625B |
| source | esp@cenet |
| title | NOVEL NPR-B AGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T11%3A51%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HELLBERG,%20MARK%20R&rft.date=2018-08-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201401625B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |